CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
4 Mar, 20:00
NYSE NYSE
$
80. 57
+0.08
+0.1%
Pre Market
$
80. 42
-0.15 -0.19%
96.93B Market Cap
11.4 P/E Ratio
0.97% Div Yield
5,374,644 Volume
7.87 Eps
$ 80.49
Previous Close
Day Range
79.67 81.09
Year Range
58.35 85.15
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS earnings report is expected in 55 days (29 Apr 2026)
CVS Stock Gains From Its Birth Control Prescribing Service Launch

CVS Stock Gains From Its Birth Control Prescribing Service Launch

CVS Health announces that nearly 400 CVS Pharmacy locations in Massachusetts have started offering hormonal contraceptive prescribing services.

Zacks | 1 year ago
CVS Health Corporation May Have Violated Securities Laws And The Schall Law Firm Invites Investors To Partake In A Case

CVS Health Corporation May Have Violated Securities Laws And The Schall Law Firm Invites Investors To Partake In A Case

LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) for violations of 10(b) and 20(a) of the Securities Excange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 3, 2023 and April 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 10, 2024.

Accesswire | 1 year ago
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 year ago
Shareholders Are Encouraged To Reach Out To The Schall Law Firm About A Lawsuit Against CVS Health Corporation For Securities Fraud

Shareholders Are Encouraged To Reach Out To The Schall Law Firm About A Lawsuit Against CVS Health Corporation For Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) for violations of 10(b) and 20(a) of the Securities Excange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 3, 2023 and April 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 10, 2024.

Accesswire | 1 year ago
Investors Who Lost Money on CVS Health Corporation (CVS) Should Contact Levi & Korsinsky About Pending Class Action - CVS

Investors Who Lost Money on CVS Health Corporation (CVS) Should Contact Levi & Korsinsky About Pending Class Action - CVS

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
CVS Health Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CVS

CVS Health Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CVS

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
FINAL CVS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds CVS Health Corporation Investors to Join the Class Action Lawsuit!

FINAL CVS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds CVS Health Corporation Investors to Join the Class Action Lawsuit!

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired CVS securities between February 9, 2022, and April 30, 2024, inclusive (the "Class Period").

Accesswire | 1 year ago
CVS Health Corporation May Have Defrauded The Public And The Schall Law Firm Invites Affected Investors To Partake In A Case

CVS Health Corporation May Have Defrauded The Public And The Schall Law Firm Invites Affected Investors To Partake In A Case

LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) for violations of 10(b) and 20(a) of the Securities Excange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 3, 2023 and April 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 10, 2024.

Accesswire | 1 year ago
Levi & Korsinsky Notifies CVS Health Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - CVS

Levi & Korsinsky Notifies CVS Health Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - CVS

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
CVS Health: Spring's Correction Offers Good Value

CVS Health: Spring's Correction Offers Good Value

After the market panicked and sold CVS in spring, the current price makes for a good opportunity. Despite setbacks in Q1 with its Health Care Benefits segment, CVS has variety of business unit and remains adaptable over time to needs of consumers and producers. As the American population ages, demand for its pharmaceutical products should also increase.

Seekingalpha | 1 year ago
Shareholders of CVS Health Corporation Should Contact Levi & Korsinsky Before September 10, 2024 to Discuss Your Rights – CVS

Shareholders of CVS Health Corporation Should Contact Levi & Korsinsky Before September 10, 2024 to Discuss Your Rights – CVS

NEW YORK, NY / ACCESSWIRE / September 9, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Shareholders that Lost Money on CVS Health Corporation(CVS) Should Contact Levi & Korsinsky About Pending Class Action - CVS

Shareholders that Lost Money on CVS Health Corporation(CVS) Should Contact Levi & Korsinsky About Pending Class Action - CVS

NEW YORK, NY / ACCESSWIRE / September 9, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Loading...
Load More